ProCE Banner Activity

Frequently Asked Questions About CMV Management

Podcast Episodes

Listen to Atul Humar, MD, FRCP(C); Hannah Imlay, MD, MS; and Raymund Razonable, MD, discuss frequently asked questions about CMV management in solid organ transplantation recipients.

Released: November 06, 2023

Share

Faculty

Atul Humar

Atul Humar, MD

Director of Transplantation 
Department of Medicine 
University of Toronto 
Toronto, Ontario, Canada 

Hannah Imlay

Hannah Imlay, MD, MS

Assistant Professor 
Internal Medicine/Infectious Diseases 
University of Utah 
Salt Lake City, Utah 

Raymund Razonable

Raymund Razonable, MD

Professor of Medicine
Division of Public Health, Infectious Diseases and Occupational Medicine
Mayo Clinic
Rochester, Minnesota 

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA

Merck & Co., Inc., Rahway, NJ, USA

Disclosure

Program Director

Atul Humar, MD

Director of Transplantation 
Department of Medicine 
University of Toronto 
Toronto, Ontario, Canada 

Atul Humar, MD: consultant/advisor/speaker: Astellas, Merck, Takeda; researcher: GSK, Merck, Qiagen; other financial material support: Eurofins-Viracor, Merck, Takeda.

Primary Author

Hannah Imlay, MD, MS

Assistant Professor 
Internal Medicine/Infectious Diseases 
University of Utah 
Salt Lake City, Utah 

Hannah Imlay, MD, MS: consultant/advisor/speaker: Medscape, UpToDate.

Raymund Razonable, MD

Professor of Medicine
Division of Public Health, Infectious Diseases and Occupational Medicine
Mayo Clinic
Rochester, Minnesota 

Raymund Razonable, MD: consultant/advisor/speaker: Novartis; researcher: Gilead, Regeneron, Roche; independent contractor: Allovir.